Discordance in investigator-reported and adjudicated sudden death in TIOSPIR

[摘要] Accurate and consistent determination of cause of death is challenging in chronic obstructive pulmonary disease (COPD) patients. TIOSPIR (N=17 135) compared the safety and efficacy of tiotropium Respimat 5/2.5 µg with HandiHaler 18 µg in COPD patients. Al

[学科分类] 呼吸医学